BARD1 Test Detected Ovarian Cancer in 82% of Patients with the Disease, Study Shows

BARD1 Test Detected Ovarian Cancer in 82% of Patients with the Disease, Study Shows
A new BARD1 Life Sciences test was able to detect ovarian cancer in 82% of those with the disease, the company announced. The 400 cases in the BARD1-Ovarian test study covered all stages and several subtypes of the cancer, it added. In addition to detecting ovarian cancer in 82% of cases, it correctly identified 79% of cancer-free controls. The

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *